Biomerica IncBMRA
▼ NegativeCapitalrelevance
Fiscal 2026 loss of $1.30 per share and revenue decline of 15.1% year over year.
Impact on stocks 1
Biotech & Genomic Medicine
Biomerica IncBiomerica reported a fiscal 2026 GAAP loss of $1.30 per share, with revenue of $4.5 million, down 15.1% year over year. As of May 31, 2026, the company held approximately $1.3 million in cash and cash equivalents, compared to $2.4 million a year earlier.
Biomerica IncFiscal 2026 loss of $1.30 per share and revenue decline of 15.1% year over year.